chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 12.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024328, is an initial spontaneous report received from a nurse on 02 DEC 2014 with a follow up information received from the nurse on 19 JAN 2015. This report refefs to a 12 years old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with FLUVIRIN 2013/2015 (seasonal influenza vaccine, batch number: 14511P expiry date: MAR 2015) intramuscularly at a dose of 0.5 ml in the right deltoid on 05 NOV 2014 at 7:00. It was reported that the patient received FLUVIRIN pre-filled syringe (PFS) that was stored at 49 degree F for 1  hour 15 minutes. The reported confirmed tha thte patient did not experience any adverse reaction following administration of incorrectly stored vaccine. Follow up information received from the nurse on 19 JAN 2015: Updated site of vaccination and reporter's comment.
Age: 12.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: case number PHEH2014US024327, is an initial spontaneous report received from a nurse on 02 DEC 2014, and with a follow up report received from nurse on 19 JAN 2015. This report refers to a 12 year old female patient. Medical history and concomitant medication were not reported. She was vaccinated with FLUVIRIN 2014/2015 (batch number: 14511P, expiry date: MAR 2015) intramuscularly at a dose of 0.5 ml on 05 NOV 2014 into right arm. Nurse reported that PFS of FLUVIRIN was store at 49 degree F for 1 hour and 15 minutes. No adverse event was reported following this maladministration (incorrect storage of drug). No further information was provided. Follow up report received from nurse on 19 JAN 2015. Updated site of vaccination.
Age: 78.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage
Clinical narrative: Case number PHEH2014US024965, is an initial spontaneous report from a nurse received on 09 DEC 2014. This report refers to a 78 year old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN 2014/2015 (batch number: 145701) intramuscularly at a dose of 0.5 ml on 06 NOV 2014. The  nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 OCT 2014 and the temperature was between 46 to 49 degree F during the excursion.
Age: 71.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024340, is an initial spontaneous report from a nurse received on 02 DEC 2014 and with follow-up from a nurse received on 19 JAN 2015. This report refers to a 71-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient had tolerated vaccines (no further details provided) well in the past. The patient was vaccinated with FLUVIRIN 2014/2015 (batch number: 14511P, expiry date: MAR 2015) intramuscularly at a dose of 0.5 ml on 20 NOV 2014. The nurse reported that FLUVIRIN prefilled syringe stored at 49 F for 1  hour and 15 minutes was administered to the patient. No adverse event reported following this medication error (incorrect storage of drug). Follow-up from a nurse received on 19 JAN 2015: Updated clinically relevant informtaimon in the narrative.
Age: 56.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage
Clinical narrative: Case number PHEH2014US024966, is an initial spontaneous report from a nurse received on 09 DEC 2014. This report refers to a 56 year old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN 2014/2015 (batch number: 145701) intramuscularly at a dose of 0.5 ml on 20 NOV 2014. The  nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 OCT 2014 and the temperature was between 46 to 49 degree F during the excursion.
Age: 32.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage
Clinical narrative: Case number PHEH2014US024967, is an initial spontaneous report from a nurse received on 09 DEC 2014. This report refers to a 32 year old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN 2014/2015 (batch number: 145701) intramuscularly at a dose of 0.5 ml on 28 OCT 2014. The  nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 OCT 2014 and the temperature was between 46 to 49 degree F during the excursion.
Age: 70.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage
Clinical narrative: Case number PHEH2014US024968, is an initial spontaneous report from a nurse received on 09 DEC 2014. This report refers to a 70 year old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN 2014/2015 (batch number: 145701) intramuscularly at a dose of 0.5 ml on 22 NOV 2014. The  nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 OCT 2014 and the temperature was between 46 to 49 degree F during the excursion.
Age: 31.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage
Clinical narrative: Case number PHEH2014US02496*, is an initial spontaneous report from a nurse received on 09 DEC 2014. This report refers to a 31 year old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN 2014/2015 (batch number: 145701) intramuscularly at a dose of 0.5 ml on 20 NOV 2014. The  nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 OCT 2014 and the temperature was between 46 to 49 degree F during the excursion.
Age: 91.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage
Clinical narrative: Case number PHEH2014US024979, is an initial spontaneous report from a nurse received on 09 DEC 2014. This report refers to a 91 year old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN 2014/2015 (batch number: 145701) intramuscularly at a dose of 0.5 ml on 13 NOV 2014. The  nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 OCT 2014 and the temperature was between 46 to 49 degree F during the excursion.
Age: 39.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage
Clinical narrative: Case number PHEH2014US024978, is an initial spontaneous report from a nurse received on 09 DEC 2014. This report refers to a 39- year-old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN 2014/2015 (batch number: 145701) intramuscularly at a dose of 0.5 ml on 16 OCT 2014. The  nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 OCT 2014 and the temperature was between 46 to 49 degree F during the excursion.
Age: 63.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage
Clinical narrative: Case number PHEH2014US024977, is an initial spontaneous report from a nurse received on 09 DEC 2014. This report refers to a 63-year-old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN 2014/2015 (batch number: 145701) intramuscularly at a dose of 0.5 ml on 17 NOV 2014. The  nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 OCT 2014 and the temperature was between 46 to 49 degree F during the excursion.
Age: 70.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage
Clinical narrative: Case number PHEH2014US024970, is an initial spontaneous report from a nurse received on 09 DEC 2014. This report refers to a 70 year old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN 2014/2015 (batch number: 145701) intramuscularly at a dose of 0.5 ml on 30 OCT 2014. The  nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 OCT 2014 and the temperature was between 46 to 49 degree F during the excursion.
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage
Clinical narrative: Case number PHEH2014US024976, is an initial spontaneous report from a nurse received on 09 DEC 2014. This report refers to a 78 year old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN 2014/2015 (batch number: 145701) intramuscularly at a dose of 0.5 ml on 30 OCT 2014. The  nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 OCT 2014 and the temperature was between 46 to 49 degree F during the excursion.
Age: 61.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024975, is an initial spontaneous report from a nurse received on 09 DEC 2014. This report refers to a 61-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN 2014/2015 (batch number: 145701) intramuscularly at a dose of 0.5 ml on 06 NOV 2014. The  nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 OCT 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event reported following this medication error (incorrect storage of drug).
Age: 67.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024974, is an initial spontaneous report from a nurse received on 09 DEC 2014. This report refers to a 67 year old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN 2014/2015 (batch number: 145701) intramuscularly at a dose of 0.5 ml on 24 NOV 2014. The  nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 OCT 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration (incorrect storage of drug).
Age: 50.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024973, is an initial spontaneous report from a nurse received on 09 DEC 2014. This report refers to a 50 year old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN 2014/2015 (batch number: 145701) intramuscularly at a dose of 0.5 ml on 04 NOV 2014. The  nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 OCT 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration (incorrect storage of drug).
Age: 51.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024972, is an initial spontaneous report from a nurse received on 09 DEC 2014. This report refers to a 51 year old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN 2014/2015 (batch number: 145701) intramuscularly at a dose of 0.5 ml on 04 NOV 2014. The  nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 OCT 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration (incorrect storage of drug).
Age: 20.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024971, is an initial spontaneous report from a nurse received on 09 DEC 2014. This report refers to a 20 year old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN 2014/2015 (batch number: 145701) intramuscularly at a dose of 0.5 ml on 11 NOV 2014. The  nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 OCT 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration (incorrect storage of drug).
Age: 16.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024964, is an initial spontaneous report from a nurse received on 09 DEC 2014. This report refers to a 16- year-old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN 2014/2015 (batch number: 145701) intramuscularly at a dose of 0.5 ml on 28 OCT 2014. The  nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 OCT 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration (incorrect storage of drug). No further information was provided.
Age: 60.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024963, is an initial spontaneous report from a nurse received on 09 DEC 2014. This report refers to a 60- year-old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN 2014/2015 (batch number: 145701) intramuscularly at a dose of 0.5 ml on 14 NOV 2014. The  nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 OCT 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration (incorrect storage of drug). No further information was provided.
Age: 63.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024962, is an initial spontaneous report from a nurse received on 09 DEC 2014. This report refers to a 63-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN 2014/2015 (batch number: 145701) intramuscularly at a dose of 0.5 ml on 16 OCT 2014. The  nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 OCT 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration (incorrect storage of drug). No further information was provided.
Age: 90.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024961, is an initial spontaneous report from a nurse received on 09 DEC 2014. This report refers to a 90- year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN 2014/2015 (batch number: 145701) intramuscularly at a dose of 0.5 ml on 03 NOV 2014. The  nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 OCT 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration (incorrect storage of drug). No further information was provided.
Age: 17.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024960, is an initial spontaneous report refers to a 17-year-old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 03 Nov 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration. No further information was provided.
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024996 is an initial spontaneous report received from a nurse on 09 Dec 2014. This report refers to a female patient whose age was not reported. Past medical history and concomitant medications were not reported. The temperature excursion of FLUVIRIN (batch number: 145701) began around 16 Oct 2014 and the patient received the vaccine intramuscularly at a dose of 0.5 ml on 03 Nov 2014. It was reported that the vaccine administered was at 49 F 12 times over a period of 34 days. There were 12 separate temperature excursions lasting 30 minutes each in which the temperature was 46 to 49 F during each of those excursions. No adverse events were reported following the maladministration.
Age: 35.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage
Clinical narrative: Case number PHEH2014US02500, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 35 year old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 11 Nov 2014. The nurse reported that  FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The events reported after the maladministration.
Age: 93.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024999, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 93 year old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number 145701) intramuscularly at a dose of 0.5 ml on 22 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was in between 46 to 49 degree F during excursion. No adverse events reported after the maladministration.
Age: 12.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024998 is an initial spontaneous report received from a nurse on 09 Dec 2014. This report refers to a 12 years old male patient. Past medical history and concomitant medications were not reported. The temperature excursion of FLUVIRIN (batch number: 145701) began around 16 Oct 2014 and the patient received the vaccine intramuscularly at a dose of 0.5 ml on 18 Nov 2014. It was reported that the vaccine administered was at 49 F 12 times over a period of 34 days. There were 12 separate temperature excursion lasting 30 minutes each in which the temperature was 46 to 49 F during each of those excursion. No adverse events were reported following the maladministration.
Age: 42.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025002, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 42 year old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 28 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was in between 46 to 49 degree F during excursion. No adverse events reported after the administration.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024995 is an initial spontaneous report received from a nurse on 09 Dec 2014. This report refers to a 54 years old female patient. Past medical history and concomitant medications were not reported. The temperature excursions of FLUVIRIN (batch number: 145701) began around 16 Oct 2014 and the patient received the vaccine intramuscularly at a dose of 0.5 ml on the same date. It was reported that the vaccine administered was at 49 F 12 times over a period of 34 days. There were 12 separate temperatures excursions lasting 30 minutes each in which the temperature was 46 to 49 F during each of those excursions. No adverse events were reported following the maladministration.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024994 is an initial spontaneous report received from a nurse on 09 Dec 2014. This report refers to a 67 years old female patient. Past medical history and concomitant medications were not reported. The temperature excursion of FLUVIRIN (batch number: 145701) began around 16 Oct 2014 and the patient received the vaccine intramuscularly at a dose of 0.5 ml on 28 Oct 2014. It was reported that the vaccine administered was at 49F 12 times over a period of 34 days. There were 12 separate temperature excursions lasting 30 minutes each in which the temperature was 46 to 49 F during each of those excursions. No adverse events were reported following the maladministration
Age: 73.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case PHEH2014US025023, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 73-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 31 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursion lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event reported following this medication error.
Age: 3.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025022, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 03-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 06 Nov 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursion lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event reporting following this medication errors.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025021, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 55-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 06 Nov 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursion lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event reported following this medication error.
Age: 50.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage
Clinical narrative: Case number PHEH2014US025020, is an initial spontaneous report from a nurse received on 09 DEC 2014. This report refers to a 50-year-old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN 2014/2015 (batch number: 145701) intramuscularly at a dose of 0.5 ml on 23 OCT 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 OCT 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event reported following this medication error (incorrect storage of drug).
Age: 39.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025019, is an initial spontaneous report received from a nurse on 09 Dec 2014. This report refers to a 39 year old female patient. Historical condition and concomitant medication were not reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml of 18 Nov 2014. The nurse reported that before administration, the FLUVIRIN had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperatures were in between 46 to 49 degree F. No adverse event was reported following this mal administration.
Age: 63.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025018, is an initial spontaneous report received from a nurse on 09 Dec 2014. This report refers to a 63 year old male patient. Historical condition and concomitant medication were not reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 12 Nov 2014. The nurse reported that before administration, the FLUVIRIN had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperatures were in between 46 to 49 degree F. No adverse event was reported following this mal administration.
Age: 92.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025017, is an initial spontaneous report received from a nurse on 09 Dec 2014. This report refers to a 92 year old female patient. Historical condition and concomitant medication were not reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 28 Oct 2014. The nurse reported that before administration, the FLUVIRIN had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperatures were in between 46 to 49 degree F. No adverse event was reported following this mal administration.
Age: 88.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025015, is an initial spontaneous report received from a nurse on 09 Dec 2014. This report refers to an 88 year old female patient. Historical condition and concomitant medication were not reported. The patient was vaccinated with FLURIVIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 16 Oct 2014. The nurse reported that before administration, the FLUVIRIN had 12 separate temperature excursion lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperatures were in between 46 to 49 degree F. No adverse event was reported following this mal administration.
Age: 33.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025014, is an initial spontaneous report received from a nurse on 09 Dec 2014. This report refers to a 33 year old female patient. Historical condition and concomitant medication were not reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 05 Nov 2014. The nurse reported that before administration, the FLUVIRIN had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperatures were in between 46 to 49 degree F. No adverse event was reported following this mal administration.
Age: 23.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025013, is an initial spontaneous report received from a nurse on 09 Dec 2014. This report refers to a 23 year old female patient. Historical condition and concomitant medication were not reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 05 Nov 2014. The nurse reported that before administration, the FLUVIRIN had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperatures were in between 46 to 49 degree F. No adverse event was reported following this mal administration.
Age: 34.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US025009 is an initial spontaneous report received from a nurse on 09 Dec 2014. This report refers to a 34 years old male patient. Past medical history and concomitant medications were not reported. The temperature excursion of FLUVIRIN (batch number: 145701) began around 16 Oct 2014 and the patient received the vaccine intramuscularly at a dose of 0.5 ml on 22 Oct 2014. It was reported that the vaccine administered was at 49 F 12 times over a period of 34 days. There were 12 separate temperatures excursions lasting 30 minutes each in which the temperature was 46 to 49 F during each of those excursions. No adverse events were reported following the maladministration.
Age: 74.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024356, is an initial spontaneous report received from a nurse on 02 Dec 2014 and with a follow-up from a nurse received on 22 Jan 2015. This report refers to a 74 years old male patient. His medical history and concomitant medications were not reported. He was vaccinated with FLUVIRIN (batch number: 14511P expiry date: Mar 2015) into left deltoid intramuscularly at a dose of 0.5 ml on 20 Nov 2014. It was reported that the patient received FLUVIRIN PFS that was stored at 49 degree F for 1 hour 15 minutes. No adverse event was reported following this maladministration. Follow-up from a nurse received on 22 Jan 2015: Site of vaccination (left deltoid) updated.
Age: 81.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024363, is an initial spontaneous report received from a nurse on 02 Dec 2014 and with follow-up from a nurse received on 19 Jan 2015. This report refers to an 81 years old female patient. Her medical history and concomitant medications were not reported. She had tolerated vaccines (no further details provided) well in the past. She was vaccinated with FLUVIRIN (batch number: 14511P, expiry date: Mar 2015) into right deltoid intramuscularly at a dose of 0.5 ml on 07 Nov 2014. Nurse reported that PFS of FLUVIRIN was stored at 49 degree F for 1 hour and 15 minutes. No adverse event was reported following this maladministration. Follow-up from a nurse received on 19 Jan 2015: Site of vaccination (right deltoid) and other clinically relevant information on previous vaccinations in the narrative was updated.
Age: 38.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024946, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 38 year old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 03 Nov 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was in between 46 to 49 degree F during excursion. No adverse events reported after the maladministration.
Sex: U
Vaccine: FLU3
Symptoms: Expired product administered, No adverse event
Clinical narrative: Case number PHEH2014US024699, is an initial spontaneous report received from a nurse on 05 Dec 2014. This report refers to a patient of unknown age and gender. Nurse reported that patient received expired FLUVIRIN (batch number: unknown) intramuscular on 05 Dec 2014. No adverse reaction was reported. No further information was provided.
Sex: M
Vaccine: FLU3
Symptoms: Influenza like illness
Clinical narrative: Case number PHEH2014US024694, is an initial spontaneous report received from a nurse on 05 Dec 2014. This report refers to a male patient of unknown age. His medical history and concomitant medication was not reported. He was vaccinated with FLUVIRIN (batch number: unknown) intramuscular on an unknown date. Shortly after vaccination the patient experienced flu like symptoms. Outcome of the event was unknown. Seriousness and causality assessment was not reported. No further information was provided.
Age: 84.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024631 is a combined initial and follow-up spontaneous report from a nurse received on 04 Dec 2014 and 09 Dec 2014. This report refers to an 84-year old female patient (previously reported as incomplete case). Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 16 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event was reported following this maladministration.
Sex: F
Vaccine: FLU3
Symptoms: Injection site discolouration
Clinical narrative: Case number PHEH2014US024445, is an initial spontaneous report received from a pharmacist on 04 DEC 2014. This report refers to a female patient of unknown age. She was vaccinated with FLUVIRIN 2014/2015 (batch number: unknown) intramuscular on an unknown date. On an unspecified date post vaccination she experienced hyperpigmentation at the site of injection. Pharmacist reported that she was taking a lot of dermatological medications (unspecified). Outcome of the event was unknown. Seriousness and causality assessment was not reported.
Age: 79.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024369, is an initial spontaneous report received from a nurse on 02 DEC 2014, with a follow up received from nurse on 21 JAN 2015. This report refers to a 79 years old male patient. His medical history was not reported. Concomitant medications were none. The patient had tolerated the vaccines well in the past. He was vaccinated with FLUVIRIN 2014/2015 (batch number: 14511P, expiry date: MAR 2015) intramuscularly at a dose of 0.5 ml into the right deltoid on 06 NOV 2014. Nurse reported that PFS of FLUVIRIN was stored at 49 degrees for 1 hour and 15 minutes. The patient did not experience any adverse reaction due to the maladministration (incorrect storage of drug). Follow up received from nurse on 21-JAN 2015: updated site of vaccination and reporter comment.
Age: 79.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage
Clinical narrative: Case number PHEH2014US024368 is an initial spontaneous report from a nurse received on 02 Dec 2014, with a follow up received from nurse on 19 Jan 2015. This report refers to a 79 years old female patient. Her medical history was not reported. Concomitant medications were none. The patient had tolerated the vaccines well in the past. The patient was vaccinated with FLUVIRIN (batch number: 14511P, expiry date: Mar 2015) intramuscularly at a dose of 0.5 ml into the right deltoid on 06 Nov 2014. The nurse reported that before vaccination the prefilled syringe of FLUVIRIN was stored at 49 degrees F for 1 hour and 15 minutes. The patient did not experience any adverse reaction due to the maladministration. Follow up received from nurse on 19 Jan 2015: updated site of vaccination and reporter comment.
Age: 79.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024367, is an initial spontaneous report received from a nurse on 02 DEC 2014, with a follow up report received from the nurse on 19 JAN 2015. This report refers to a 79 year old female patient. Historical condition and concomitant medication were not reported. her past vaccinations (unspecified) were well tolerated. The patient was vaccinated with the initial application of FLUVIRIN 2014/2015 (batch number: 14511P, expiry date: MAR 2015) intramuscularly in right deltoid at a dose of 0.5 ml on 13 NOV 2014. The nurse reported that before vaccination the prefilled syringe (PFS) of FLUVIRIN was stored at 49 degree F for 1 hour and 15 minutes. Patient did not experience any adverse event. No adverse event was reported following this maladministration (incorrect storage of drug). No further information was provided. Follow up report received from the nurse on 19 JAN 2015: Updated vaccination history, recent vaccination site and reporter's statement.
Age: 80.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024366, is an initial spontaneous report received from a nurse on 02 DEC 2014, with a follow up received from  nurse on 21 JAN 2015. This report refers to an 80 years old male patient. His medical history was not reported. Concomitant medications were none. The patient had tolerated the vaccines well in the past. He was vaccinated with FLUVIRIN 2014/2015 (batch number: 14511P, expiry date: MAR 2015) intramuscularly into the left deltoid at a dose of 0.5 ml on 03 NOV 2014. Nurse reported that PFS of FLUVIRIN was stored at 49 degree F for 1 hour and 15 minutes. The patient did not experience any adverse reaction due to the maladministration (incorrect storage of drug). Follow up received from nurse on 21 JAN 2015: Updated site of vaccination and reporter comment.
Age: 80.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024365, is an initial spontaneous report received from a nurse on 02 DEC 2014, with a follow up report received from the nurse on 19 JAN 2015. This report refers to a 80 years old female patient. Historical condition and concomitant medication were not reported. her past vaccinations (unspecified) were well tolerated. The patient was vaccinated with the initial application of FLUVIRIN 2014/2015 (batch number: 14511P, expiry date: MAR 2015) intramuscularly in right deltoid at a dose of 0.5 ml on 10 NOV 2014. The nurse reported that before vaccination the prefilled syringe (PFS) of FLUVIRIN was stored at 49 degree F for 1 hour and 15 minutes. Patient did not experience any adverse event. No adverse event was reported following this maladministration (incorrect storage of drug). No further information was provided. Follow up report received from the nurse on 19 JAN 2015: Vaccination history and site of FLUVIRIN were updated.
Age: 81.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024364, is an initial spontaneous report received from a nurse on 21 JAN 2014, with a follow-up report received from the nurse on 19 JAN 2015. This report refers to a 81 year old female patient. Historical condition and concomitant medication were not reported. her past vaccinations (unspecified) were well tolerated. The patient was vaccinated with the initial application of FLUVIRIN 2014/2015 (batch number: 14511P, expiry date: MAR 2015) intramuscularly in right deltoid at a dose of 0.5 ml on 06 NOV 2014. The nurse reported that before vaccination the prefilled syringe (PFS) of FLUVIRIN was stored at 49 degree F for 1 hour and 15 minutes.  No adverse event was reported following this maladministration (incorrect storage of drug). No further information was provided. Follow-up from a nurse received on 21 JAN 2015: Site of vaccination (right deltoid) and other clinically relevant information on previous vaccinations in the narrative was updated.
Age: 82.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024362, is an initial spontaneous report received from a nurse on 02 Dec 2014 with a follow up information received from the nurse on 19 Jan 2015. This report refers to an 82 years old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with FLUVIRIN (batch number: 14511P, expiry date: Mar 2015) intramuscularly at a dose of 0.5 ml in the left deltoid on 07 Nov 2014. Nurse reported that pre-filled syringe (PFS) of FLUVIRIN was stored at 49 degree F for 1 hours and 15 minutes. The reported confirmed that the patient did not experience any adverse reaction following administration of incorrectly stored vaccine. No further information was provided. Follow up information received from the nurse on 19 Jan 2015: Updated site of vaccination and reporter's comment.
Age: 84.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024361, is an initial spontaneous report received from a nurse on 02 Dec 2014 and with a follow-up from a nurse received on 21 Jan 2015. This report refers to an 84 years old male patient. His medical history and concomitant medications were not reported. He had tolerated vaccines (no further details provided) well in the past. He was vaccinated with FLUVIRIN (batch number: 14511P expiry date: Mar 2015) into left deltoid intramuscularly at a dose of 0.5 ml on 07 Nov 2014. It was reported that the patient received FLUVIRIN PFS that was stored at 49 degree F for 1 hour 15 minutes. No adverse event was reported following this maladministration. Follow-up from a nurse received on 21 Jan 2015: Site of vaccination (left deltoid) and other clinically relevant information on previous vaccinations in the narrative was updated.
Age: 87.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024360, is an initial spontaneous report received from a nurse on 02 Dec 2014 and with a follow-up from a nurse received on 22 Jan 2015. This report refers to an 87 years old male patient. His medical history and concomitant medications were not reported. He had tolerated vaccines (no further details provided) well in the past. He was vaccinated with FLUVIRIN (batch number: 14511P expiry date: Mar 2015) into right deltoid intramuscularly at a dose of 0.5 ml on 13 Nov 2014. It was reported that the patient received FLUVIRIN PFS that was stored at 49 degree F for 1 hour 15 minutes. No adverse event was reported following this maladministration. Follow-up from a nurse received on 22 Jan 2015: Site of vaccination (right deltoid) and other clinically relevant information on previous vaccinations in the narrative was updated.
Age: 89.0
Sex: F
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024359, is an initial spontaneous report received from a nurse on 02 Dec 2014 and with a follow-up from a nurse received on 21 Jan 2015. This report refers to an 89 years old female patient. Her medical history and concomitant medications were not reported. She had tolerated vaccines (no further details provided) well in the past. She was vaccinated with FLUVIRIN (batch number: 14511P expiry date: Mar 2015) into left deltoid intramuscularly at a dose of 0.5 ml on 12 Nov 2014. It was reported that the patient received FLUVIRIN PFS that was stored at 49 degree F for 1 hour 15 minutes. No adverse event was reported following this maladministration. Follow-up from a nurse received 21 Jan 2015: Site of vaccination (left deltoid) and other clinically relevant information on previous vaccinations in the narrative was updated.
Age: 74.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024358, is an initial spontaneous report received from a nurse on 02 Dec 2014 and with a follow-up from a nurse received on 21 Jan 2015. This report refers to a 74 year old male patient. Medical history and concomitant medication were not reported. He had tolerated vaccines (no further details provided) well in the past. He was vaccinated with FLUVIRIN (batch number 14511P, expiry date: Mar 2015) into left deltoid intramuscularly at a dose of 0.5 ml on 20 Nov 2014. Nurse reported that PFS of FLUVIRIN was stored at 49 degree F for 1 hour and 15 minutes. No adverse event was reported following this maladministration. No further information was provided. Follow-up from a nurse received on 21 Jan 2015: Site of vaccination (left deltoid) and other clinically relevant information on previous vaccinations in the narrative was updated.
Age: 75.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Case number PHEH2014US024357, is an initial spontaneous report from a nurse received on 02 Dec 2014 and a follow up report received from the nurse on 19 Jan 2015. This report refers to a 75-year-old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 14511P, expiry date: Mar 2015) intramuscularly in the left deltoid at a dose of 0.5 ml on 05 Nov 2014. The nurse reported that before vaccination the prefilled syringe (PFS) of FLUVIRIN was stored at 49 degree F for 1 hour and 15 minutes. No adverse event was reported following this maladministration (incorrect storage of drug). No further information was provided. Follow up report received from the nurse on 19 Jan 2015: FLUVIRIN site of vaccination was updated.